Thrilled to share a new preprint on the role of RNU4-2 and RNU5B-1 variants in neurodevelopmental disorders, now online in MedRxiv. 1/12 🧵https://t.co/uCjD4WSWUD
We did it: Nature genetics cover story. Incredible team and collaborators & great science. Good to see #ATAXIA science so recognized. A devastating disease for many. @NatureGenet@DavidPellerin_2@HIHGatUM@TheNeuro_MNI@NAF_Ataxia https://t.co/msrs3XkDtq
https://t.co/w76SYVH3fc
Our Nature genetics paper is out. After 12 months of reviews and many improvements! We identified a common 17bp sequence motif (not just on one haplotype) in front of the FGF14-GAA repeat that fully stabilizes the tandem repeat locus: no intergenerational expansion in thousands of chromosomes beyond 30 repeats. This could be a mechanistic blueprint and a therapeutic opportunity for other dynamic genetic loci causing disease ...
FGF14/SCA27B is the major dominant genetic ataxia locus accounting for ~15% of all ataxia patients worldwide - in East Canada for up to 60% of all ataxia cases.
https://t.co/e1zjiUcrTq
We thank all supporters, of this important story:
@NAF_Ataxia@davidPellerin_2@Egor_Dolzhenko@AllofUsResearch @GabrielMatosRo5 @BillNye@MikeEberle @Gianina_Natoli #Schahram Akbarian #Marek Napierala #Tomi Pastinen #bernardBrais #MattDanzi #sca27b
Incredible quick progress for one of the most common types ataxia: GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohort - eBioMedicine https://t.co/FLtSSd9SIi
🎉 Our IMSGC and MultipleMS work on genetic determinants of multiple sclerosis (MS) severity is out in Nature! Read for the main findings of the study, led by myself and co-advised by Sergio Baranzini and Stephen Sawcer. #MS#Genetics 🧬
https://t.co/zRP9baRrHQ
this is NOVEL and very intriguing: we identified a common sequence alteration that predicts the stability of the adjacent tandem repeat locus of one of the major genetic ataxia loci, FGF14/SCA27B.
https://t.co/rMcbifjqBR
@NAF_ataxia@davidPellerin_2@Egor_Dolzhenko#bernardBrais #MattDanzi
RFS: reference 5’-flanking sequence
CFV: common 5’-flanking variant
FGF14, one of the most important genetic ataxias might be moving closer to therapy within months of discovery. Congrats to Prof Matthis Synofzik and team @uni_tue@HertieNeuroSci
https://t.co/SQCjyIJ6nR
Our latest dive into AI and a "first in class tool": "RExPRT: a machine learning tool to predict pathogenicity of tandem repeat loci"
https://t.co/llToNn14He
Special kudos to Sarah Fazal, PhD and Vanessa Aguiar-Pulido, PhD. @vaguiarpulido, @univmiami
The key question behind this work: With over 1.7 million short tandem repeats now identified, which ones should we prioritize in disease studies?
Happy to share our new preprint article describing an optimized testing strategy for the diagnosis of GAA-FGF14 #ataxia.
@Univ_Lorraine @mcgillu@TheNeuro_MNI@umiamimedicine@UCLIoN
https://t.co/xspuudO5Ki
A study published in the New England Journal of #Medicine (@NEJM) featuring Miller School researchers shows how a variation in the gene FGF14 causes a common form of late-onset cerebellar #ataxia, a #BrainDisorder that interferes with coordinated movement.https://t.co/M5H9OUBdiz
I am thrilled to share this international work led by @DavidPellerin_2, MC Danzi, @szuchner, and Bernard Brais, with which the Neurological Tissue Bank- Biobank @hospitalclinic@IDIBAPS have collaborated.
Just out: our discovery of THE major late onset ataxia gene. Thank you #mattdanzi! This will have major implications for late onset disease genetic research and therapy. Best part are our awesome collaborators at McGill #bernardbrais and #davidpellerin. https://t.co/B6kMnQZG2w
In this study, a large repeat expansion in a noncoding part of FGF14 was found to cause late-onset cerebellar ataxia, which underscores the importance of noncoding regions in the search for causes of disease. https://t.co/J57HJKdPck